GIC is open to partnerships and licensing arrangements related to our pharmaceutical operations. Over our 35-year history, we have developed numerous proprietary processes to produce small batch molecules faster, cheaper, with higher quality, higher yield and greater repeatability. GIC has perfected the art of single pot chemistry. We have perfected the ability to do all but the last ring substitutions in-house, delivering to you a molecule that is one-step removed from finished product.

Our techniques and processes have never been published or patented. GIC has what we refer to as “Black Box IP”, meaning our partners will benefit from a full-length IP runway.

We sell small molecules globally. We are now looking to partner with a global player and take our company to the next level.